Cookies on the Business Insider India website

Business Insider India has updated its Privacy and Cookie policy. We use cookies to ensure that we give you the better experience on our website. If you continue without changing your settings, we\'ll assume that you are happy to receive all cookies on the Business Insider India website. However, you can change your cookie setting at any time by clicking on our Cookie Policy at any time. You can also see our Privacy Policy.

Alembic Pharma gets EIR from USFDA for API facility at Karakhadi

Mar 17, 2020, 12:23 IST

PTI

New Delhi, Mar 17 () Alembic Pharmaceuticals on Tuesday said it has received an EIR from the US health regulator after inspection of its active pharmaceutical ingredient (API) facility at Karakhadi in Gujarat.

The inspection was conducted during January 13-17.

"The company has received Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for the inspection carried out by them at our API facility at Karakhadi," the drug firm said in a filing to the BSE.

Shares of Alembic Pharma were trading at Rs 534.00 apiece on the BSE, up 0.55 per cent from the previous close. SID

SID ANUANU

(This story has not been edited by www.businessinsider.in and is auto–generated from a syndicated feed we subscribe to.)